From the first launch to ongoing market access operational execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We deliver Pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and business process infrastructure for market access and therapy commercialization.
Solutions overview
IntegriChain delivers the life science industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, managed services and expert advisors to power their operations and harness the value of their channel, patient and payer data.
View all products
To ensure you get the most out of your access and commercialization investment, IntegriChain provides a complete set of professional Advisory and Systems Integration Services designed to further your business and success.
Services overview
IntegriChain provides wide array of resources to help you navigate your journey to market access success.
Resources overview
We help all stakeholders in the life sciences industry drive access. We do this through our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts and pricing, gross-to-net, channel, and patient services – unlocking strategic payer, provider, pharmacy and patient access insights for our life sciences customers.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, Market Access experts, analysts, technologies, and advisory professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
September 10, 2020
Philadelphia, PA, September 10, 2020 – IntegriChain, a leading data and managed services company helping Life Sciences manufacturers deliver access to innovative therapies that significantly improve patient lives, today announced that registration is now open for the Access Insights Virtual Summit 2020, to be held October 20 to 22, 2020. The summit includes thought leadership sessions focused on addressing key market access challenges for Life Sciences manufacturers. Details and registration for the summit can be found at https://www.integrichain.com/access-insights/.
“The Life Sciences industry has shown its resiliency and laser focus on serving patients in need throughout the pandemic while still pressing forward on critical business strategies to overcome access barriers,” said Josh Halpern, IntegriChain Co-Founder and EVP of Product and Strategy. “We are very happy to respond to popular demand and present our deep-value Access Insights sessions through a convenient, flexible virtual format this year. During the summit, we will share our data-driven insights and product vision to solve the industry’s key market access challenges, including the strategic business case for unifying Market Access data and business processes, achieving data excellence by integrating channel and patient data with enterprise data and applications platforms, and the business value for creating an agile market access business. We will miss seeing all our great customers and industry colleagues in person this year, but like the industry itself, our Access Insights event is resilient and will adjust to fit the needs of the times in the best way possible for our customers.”
Given travel and gathering restrictions due the pandemic, the Access Insights Virtual Summit replaces IntegriChain’s annual in-person, three-day conference, attended by more than 250 market access leaders and professionals. IntegriChain expects to resume the in-person conference in October 2021 in Orlando, Florida.
About IntegriChain IntegriChain delivers Life Sciences’ only comprehensive data and business process platform for market access. More than 240 manufacturers rely on IntegriChain’s ICyte Platform of analytics, applications, managed services and expert advisors to power their market access operations and harness the value of their channel, patient and payer data. IntegriChain is backed by Accel-KKR, a leading Silicon Valley technology private equity firm. The company is headquartered in Philadelphia, PA, with offices in Ambler, PA; Somerset, NJ, Raleigh, NC, and Pune, India. For more information, visit www.integrichain.com, or follow us on Twitter @IntegriChain and LinkedIn.
Contact Jennifer Guinan | Sage Strategic Marketing | 610.410.8111 | Jennifer@sagestrat.com
Register Now
Webinars & Resources
See List
